Form 4: QLYS director Kristi Rogers reports sale reducing holdings to 8,596
Rhea-AI Filing Summary
Form 4 shows that Kristi Marie Rogers, a director of Qualys, Inc. (QLYS), sold 1,700 shares of the company's common stock on 08/22/2025 at a reported price of $134.7047 per share. After this sale she beneficially owned 8,596 shares, held directly. The filing was signed on 08/25/2025 by Bruce Posey as attorney-in-fact.
Positive
- None.
Negative
- None.
Insights
TL;DR: A director reported a routine sale of shares, reducing direct holdings to 8,596 shares; no additional context provided.
The filing documents a single non-derivative sale by a director on 08/22/2025 for 1,700 shares at $134.7047 each. The report identifies the seller as a director and shows direct ownership following the sale. There is no indication of a Rule 10b5-1 plan, no related-party transactions, and no change in officer status. This appears to be a standard insider disclosure without further corporate-governance implications stated in the form.
TL;DR: Insider sale recorded; transaction details are limited to share count, price, and resulting ownership—no financial performance data included.
The report provides precise transaction data: sale date 08/22/2025, 1,700 shares sold at $134.7047, leaving 8,596 shares beneficially owned directly. No derivative transactions or additional trades are reported. Because the form contains only this single sale and no accompanying commentary or broader trading pattern, its standalone material impact on valuation or liquidity cannot be determined from this filing alone.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,700 | $134.7047 | $229K |
Footnotes (1)
FAQ
What transaction is reported for QLYS on this Form 4?
When was the Form 4 signed and by whom?
Does the Form 4 report any derivative transactions or Rule 10b5-1 plan?
What is the reporting person’s relationship to Qualys (QLYS)?